{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:41:30Z","timestamp":1790005290809,"version":"4.0.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.urolonc.2018.09.007","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T20:10:22Z","timestamp":1539634222000},"page":"531.e9-531.e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Heat shock proteins 60 and 70 are associated with long-term outcome of T1-stage high-grade urothelial tumors of the bladder treated with intravesical Bacillus Calmette-Gu\u00e9rin immunotherapy"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3855-0211","authenticated-orcid":false,"given":"Roy","family":"Mano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Zilber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo G.","family":"Di Natale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kedar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Lifshitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Yossepowitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Baniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0622-4211","authenticated-orcid":false,"given":"David","family":"Margel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2018.09.007_bib0001","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: a global overview and recent trends","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.09.007_bib0002","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.09.007_bib0003","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2018.09.007_bib0004","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol."},{"key":"10.1016\/j.urolonc.2018.09.007_bib0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1379\/CSC-99r.1","article-title":"Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications","volume":"10","author":"Ciocca","year":"2005","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.urolonc.2018.09.007_bib0006","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0090-4295(02)02289-6","article-title":"Clinical significance of heat shock protein-70 expression in bladder cancer","volume":"61","author":"Syrigos","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2018.09.007_bib0007","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.urolonc.2011.07.007","article-title":"Small interfering RNA targeting heat shock protein 70 enhances chemosensitivity in human bladder cancer cells","volume":"31","author":"Behnsawy","year":"2013","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2018.09.007_bib0008","first-page":"4579","article-title":"Heat shock protein-90, IL-6 and IL-10 in bladder cancer","volume":"20","author":"Cardillo","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1016\/j.urolonc.2018.09.007_bib0009","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/cncr.11594","article-title":"Heat shock proteins HSP27, HSP60, HSP70, and HSP90: expression in bladder carcinoma","volume":"98","author":"Lebret","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2018.09.007_bib0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.eururo.2010.10.008","article-title":"Stress proteins and cytokines are urinary biomarkers for diagnosis and staging of bladder cancer","volume":"59","author":"Margel","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.09.007_bib0011","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.eururo.2006.06.006","article-title":"HSP90 expression: a new predictive factor for BCG response in stage Ta-T1 grade 3 bladder tumours","volume":"51","author":"Lebret","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.09.007_bib0012","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.09.007_bib0013","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.juro.2013.07.102","article-title":"Defining progression in nonmuscle invasive bladder cancer: it is time for a new, standard definition","volume":"191","author":"Lamm","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2018.09.007_bib0014","doi-asserted-by":"crossref","first-page":"e51862","DOI":"10.1371\/journal.pone.0051862","article-title":"Cutoff finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization","volume":"7","author":"Budczies","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.urolonc.2018.09.007_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccell.2016.05.004","article-title":"Comprehensive transcriptional analysis of early-stage urothelial carcinoma","volume":"30","author":"Hedegaard","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.urolonc.2018.09.007_bib0016","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.eururo.2009.04.038","article-title":"An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guerin for non-muscle-invasive bladder cancer","volume":"56","author":"Malmstrom","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.09.007_bib0017","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrurol.2014.15","article-title":"The mechanism of action of BCG therapy for bladder cancer\u2014a current perspective","volume":"11","author":"Redelman-Sidi","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2018.09.007_bib0018","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.eururo.2013.07.021","volume":"65","author":"Brausi","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.09.007_bib0019","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nrurol.2013.108","article-title":"The role of heat shock proteins in bladder cancer","volume":"10","author":"Ischia","year":"2013","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2018.09.007_bib0020","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1074\/jbc.M705904200","article-title":"Hsp60 regulation of tumor cell apoptosis","volume":"283","author":"Ghosh","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urolonc.2018.09.007_bib0021","doi-asserted-by":"crossref","first-page":"31688","DOI":"10.1074\/jbc.M704129200","article-title":"Human heat shock protein 70 enhances tumor antigen presentation through complex formation and intracellular antigen delivery without innate immune signaling","volume":"282","author":"Bendz","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urolonc.2018.09.007_bib0022","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1515\/BC.2003.030","article-title":"Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94","volume":"384","author":"Gross","year":"2003","journal-title":"Biol Chem"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814391830348X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814391830348X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:14:44Z","timestamp":1761041684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107814391830348X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S107814391830348X"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2018.09.007","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heat shock proteins 60 and 70 are associated with long-term outcome of T1-stage high-grade urothelial tumors of the bladder treated with intravesical Bacillus Calmette-Gu\u00e9rin immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2018.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}